Get the Stockscreener App
6.05
3.97%
-0.25
After Hours:
6.02
-0.03
-0.50%
Kura Oncology Inc stock is traded at $6.05, with a volume of 942.16K.
It is down -3.97% in the last 24 hours and up +4.85% over the past month.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
See More
Previous Close:
$6.30
Open:
$6.19
24h Volume:
942.16K
Relative Volume:
0.75
Market Cap:
$523.78M
Revenue:
-
Net Income/Loss:
$-168.09M
P/E Ratio:
-2.788
EPS:
-2.17
Net Cash Flow:
$-138.01M
1W Performance:
-6.49%
1M Performance:
+4.85%
6M Performance:
-23.51%
1Y Performance:
-70.93%
1-Day Range:
$6.015
$6.285
1-Week Range:
$6.015
$6.59
52-Week Range:
$5.41
$21.57
Kura Oncology Inc Stock (KURA) Company Profile
Name
Kura Oncology Inc
Sector
Industry
Phone
(858) 500-8800
Address
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Compare KURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
6.05 | 545.42M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-14-24 | Downgrade | Stifel | Buy → Hold |
| Dec-22-23 | Initiated | Mizuho | Buy |
| Aug-11-23 | Initiated | BofA Securities | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Perform |
| May-17-23 | Initiated | BTIG Research | Buy |
| Jan-31-23 | Initiated | Stifel | Buy |
| Jul-12-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-15-22 | Initiated | Jefferies | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Dec-07-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Nov-05-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Initiated | Credit Suisse | Outperform |
| May-05-20 | Initiated | Barclays | Overweight |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Nov-09-18 | Initiated | Piper Jaffray | Overweight |
| Aug-01-18 | Initiated | H.C. Wainwright | Buy |
| Oct-13-16 | Resumed | Leerink Partners | Outperform |
| Jan-22-16 | Initiated | JMP Securities | Mkt Outperform |
| Dec-30-15 | Initiated | Oppenheimer | Outperform |
| Dec-16-15 | Initiated | Citigroup | Buy |
View All
Kura Oncology Inc Stock (KURA) Latest News
What makes Kura Oncology Inc. stock price move sharplyWealth Building Insights With Low Risk - jammulinksnews.com
Kura Oncology Sets Q2 Earnings Date: Cancer Drug Pipeline Update Coming August 7 - Stock Titan
Kura Oncology to Report Second Quarter 2025 Financial Results - The Manila Times
What institutional investors are buying Kura Oncology Inc. stockValue Investing Picks For Consistent Profits - jammulinksnews.com
Using flow based indicators on Kura Oncology Inc.Real-Time AI Generated Market Forecast - Newser
Investor Network: Kura Oncology, Inc. to Host Earnings Call - ACCESS Newswire
Kura Oncology Inc. Recovery Potential Based on Technical ToolsWeekly Return Pick Forecast Reports Show Trend - metal.it
How to use a screener to detect Kura Oncology Inc. breakoutsSwing Trade Signal and Price Prediction - Newser
What are analysts’ price targets for Kura Oncology Inc. in the next 12 monthsStock Strategy Recommendation For Every Investor - jammulinksnews.com
Cwm LLC Purchases 25,497 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
What are the latest earnings results for Kura Oncology Inc.Dynamic profit expansion - jammulinksnews.com
What catalysts could drive Kura Oncology Inc. stock higher in 2025Record-setting profit potential - jammulinksnews.com
Is Kura Oncology Inc. a Top Dividend Stock to Watch in 2025Minimized Risk Maximum Return - metal.it
What is Kura Oncology Inc. company’s growth strategyRapid growth opportunities - jammulinksnews.com
Is Kura Oncology Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Discussion Group - Newser
Kura Oncology Inc. Stock Analysis and ForecastSuperior investment outcomes - PrintWeekIndia
Will Kura Oncology Inc. stock benefit from interest rate changesPhenomenal capital gains - jammulinksnews.com
Can Kura Oncology Inc. stock recover from recent declineGame-changing returns - jammulinksnews.com
What analysts say about Kura Oncology Inc. stockOverwhelming financial success - PrintWeekIndia
Is Kura Oncology Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional
What drives Kura Oncology Inc. stock priceAccelerated wealth building - jammulinksnews.com
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Why Kura Oncology Inc. stock attracts strong analyst attentionFree AI-Driven Trading Strategies - Newser
Kura Oncology Inc Stock (KURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):